Refanezumab (GSK249320) is an IgG1 humanized monoclonal antibody that crosses the blood-brain barrier (BBB) and targets myelin-associated glycoprotein (MAG) for the study of neurological and cardiovascular diseases.
Purity:
98.70%
CAS Number:
[1233953-61-1]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted